Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 May;65(5):1773–1785. doi: 10.1128/iai.65.5.1773-1785.1997

Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.

C Citti 1, M F Kim 1, K S Wise 1
PMCID: PMC175216  PMID: 9125561

Abstract

Variation in Vlp surface proteins of Mycoplasma hyorhinis was evaluated in terms of its role in determining susceptibility of organisms to growth inhibition by host antibodies (Abs). High-frequency switching of Vlp surface lipoproteins has been studied in isogenic lineages of M. hyorhinis SK76. In these lineages, the products of three genes, vlpA, vlpB, and vlpC, are subject to phase and size variation in vitro, which occur through distinct mutator elements that independently govern the expression of each vlp gene (promoter mutations) or the size of the vlp gene product (by intragenic expansion or contraction of a 3' region containing tandem repeats). Isogenic clonal variants of M. hyorhinis SK76 expressing distinct profiles of Vlp products were assessed for their susceptibility to complement-independent growth inhibition by serum Abs of swine experimentally infected with the arthritigenic SK76 strain. Invariably, variants expressing longer versions of VlpA, VlpB, or VlpC (each expressed individually) were completely resistant to host immune serum Abs, whereas variants expressing shorter allelic versions of each Vlp were susceptible. The target of growth-inhibiting Abs was not the Vlp products, since removal of anti-Vlp Abs had no effect on the inhibitory activity of the host immune serum on susceptible variants. Escape variant populations derived by propagating susceptible variants in an immune (versus control) host serum revealed a strong selection for the long-Vlp phenotype, irrespective of the identity of the Vlp expressed. Apparent mutational pathways of acquiring the protective phenotype included mutational switches to express long vlp genes that had been transcriptionally silent or switches to elongate expressed vlp genes. These results suggest that a major function of the Vlp system is to shield the wall-less mycoplasma surface from host Abs capable of binding vital (and as-yet-unidentified) surface antigens of this organism.

Full Text

The Full Text of this article is available as a PDF (981.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aydintug M. K., Gu Y., Philipp M. T. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun. 1994 Nov;62(11):4929–4937. doi: 10.1128/iai.62.11.4929-4937.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbour A. G. Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol. 1990;44:155–171. doi: 10.1146/annurev.mi.44.100190.001103. [DOI] [PubMed] [Google Scholar]
  3. Baseman J. B., Lange M., Criscimagna N. L., Giron J. A., Thomas C. A. Interplay between mycoplasmas and host target cells. Microb Pathog. 1995 Aug;19(2):105–116. doi: 10.1006/mpat.1995.0050. [DOI] [PubMed] [Google Scholar]
  4. Bhugra B., Voelker L. L., Zou N., Yu H., Dybvig K. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol Microbiol. 1995 Nov;18(4):703–714. doi: 10.1111/j.1365-2958.1995.mmi_18040703.x. [DOI] [PubMed] [Google Scholar]
  5. Black F. T. Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl Microbiol. 1973 Apr;25(4):528–533. doi: 10.1128/am.25.4.528-533.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bork P., Ouzounis C., Casari G., Schneider R., Sander C., Dolan M., Gilbert W., Gillevet P. M. Exploring the Mycoplasma capricolum genome: a minimal cell reveals its physiology. Mol Microbiol. 1995 Jun;16(5):955–967. doi: 10.1111/j.1365-2958.1995.tb02321.x. [DOI] [PubMed] [Google Scholar]
  7. Borst P., Greaves D. R. Programmed gene rearrangements altering gene expression. Science. 1987 Feb 6;235(4789):658–667. doi: 10.1126/science.3544215. [DOI] [PubMed] [Google Scholar]
  8. Borst P. How mycoplasma ring the changes. Curr Biol. 1992 Jun;2(6):304–306. doi: 10.1016/0960-9822(92)90878-e. [DOI] [PubMed] [Google Scholar]
  9. Bricker T. M., Boyer M. J., Keith J., Watson-McKown R., Wise K. S. Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect Immun. 1988 Feb;56(2):295–301. doi: 10.1128/iai.56.2.295-301.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brunham R. C., Plummer F. A., Stephens R. S. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun. 1993 Jun;61(6):2273–2276. doi: 10.1128/iai.61.6.2273-2276.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brunner H., James W. D., Horswood R. L., Chanock R. M. Measurement of Mycoplasma pneumoniae mycoplasmacidal antibody in human serum. J Immunol. 1972 Jun;108(6):1491–1498. [PubMed] [Google Scholar]
  12. Citti C., Wise K. S. Mycoplasma hyorhinis vlp gene transcription: critical role in phase variation and expression of surface lipoproteins. Mol Microbiol. 1995 Nov;18(4):649–660. doi: 10.1111/j.1365-2958.1995.mmi_18040649.x. [DOI] [PubMed] [Google Scholar]
  13. Cleavinger C. M., Kim M. F., Im J. H., Wise K. S. Identification of mycoplasma membrane proteins by systematic Tn phoA mutagenesis of a recombinant library. Mol Microbiol. 1995 Oct;18(2):283–293. doi: 10.1111/j.1365-2958.1995.mmi_18020283.x. [DOI] [PubMed] [Google Scholar]
  14. Cleavinger C. M., Kim M. F., Wise K. S. Processing and surface presentation of the Mycoplasma hyorhinis variant lipoprotein VlpC. J Bacteriol. 1994 Apr;176(8):2463–2467. doi: 10.1128/jb.176.8.2463-2467.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Coleman J. L., Rogers R. C., Benach J. L. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect Immun. 1992 Aug;60(8):3098–3104. doi: 10.1128/iai.60.8.3098-3104.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dudler R., Schmidhauser C., Parish R. W., Wettenhall R. E., Schmidt T. A mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cells. EMBO J. 1988 Dec 1;7(12):3963–3970. doi: 10.1002/j.1460-2075.1988.tb03283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Duncan J. R., Ross R. F. Experimentally induced Mycoplasma hyorhinis arthritis of swine: pathologic response to 26th postinoculation week. Am J Vet Res. 1973 Mar;34(3):363–366. [PubMed] [Google Scholar]
  18. Feldmann R. C., Henrich B., Kolb-Bachofen V., Hadding U. Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination. Infect Immun. 1992 Jan;60(1):166–174. doi: 10.1128/iai.60.1.166-174.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fraser C. M., Gocayne J. D., White O., Adams M. D., Clayton R. A., Fleischmann R. D., Bult C. J., Kerlavage A. R., Sutton G., Kelley J. M. The minimal gene complement of Mycoplasma genitalium. Science. 1995 Oct 20;270(5235):397–403. doi: 10.1126/science.270.5235.397. [DOI] [PubMed] [Google Scholar]
  20. Girón J. A., Lange M., Baseman J. B. Adherence, fibronectin binding, and induction of cytoskeleton reorganization in cultured human cells by Mycoplasma penetrans. Infect Immun. 1996 Jan;64(1):197–208. doi: 10.1128/iai.64.1.197-208.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gois M., Kuksa F., Franz J., Taylor-Robinson D. The antigenic differentiation of seven strains of Mycoplasma hyorhinis by growth-inhibition, metabolism-inhibition, latex-agglutination, and polyacrylamide-gel-electrophoresis tests. J Med Microbiol. 1974 Feb;7(1):105–115. doi: 10.1099/00222615-7-1-105. [DOI] [PubMed] [Google Scholar]
  22. Hayflick L., Stanbridge E. Isolation and identification of mycoplasma from human clinical materials. Ann N Y Acad Sci. 1967 Jul 28;143(1):608–621. doi: 10.1111/j.1749-6632.1967.tb27705.x. [DOI] [PubMed] [Google Scholar]
  23. Himmelreich R., Hilbert H., Plagens H., Pirkl E., Li B. C., Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 1996 Nov 15;24(22):4420–4449. doi: 10.1093/nar/24.22.4420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jensen L. T., Ladefoged S., Birkelund S., Christiansen G. Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552. Infect Immun. 1995 Sep;63(9):3336–3347. doi: 10.1128/iai.63.9.3336-3347.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ladefoged S. A., Jensen L. T., Brock B., Birkelund S., Christiansen G. Analysis of 0.5-kilobase-pair repeats in the Mycoplasma hominis lmp gene system and identification of gene products. J Bacteriol. 1996 May;178(10):2775–2784. doi: 10.1128/jb.178.10.2775-2784.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Le Grand D., Solsona M., Rosengarten R., Poumarat F. Adaptive surface antigen variation in Mycoplasma bovis to the host immune response. FEMS Microbiol Lett. 1996 Nov 1;144(2-3):267–275. doi: 10.1111/j.1574-6968.1996.tb08540.x. [DOI] [PubMed] [Google Scholar]
  27. Lenski R. E., Mittler J. E. The directed mutation controversy and neo-Darwinism. Science. 1993 Jan 8;259(5092):188–194. doi: 10.1126/science.7678468. [DOI] [PubMed] [Google Scholar]
  28. Lysnyansky I., Rosengarten R., Yogev D. Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangements. J Bacteriol. 1996 Sep;178(18):5395–5401. doi: 10.1128/jb.178.18.5395-5401.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Markham P. F., Glew M. D., Sykes J. E., Bowden T. R., Pollocks T. D., Browning G. F., Whithear K. G., Walker I. D. The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett. 1994 Oct 3;352(3):347–352. doi: 10.1016/0014-5793(94)00991-0. [DOI] [PubMed] [Google Scholar]
  30. Merchante R., Pooley H. M., Karamata D. A periplasm in Bacillus subtilis. J Bacteriol. 1995 Nov;177(21):6176–6183. doi: 10.1128/jb.177.21.6176-6183.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Restrepo B. I., Barbour A. G. Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell. 1994 Sep 9;78(5):867–876. doi: 10.1016/s0092-8674(94)90642-4. [DOI] [PubMed] [Google Scholar]
  32. Riethman H. C., Boyer M. J., Wise K. S. Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis. Infect Immun. 1987 May;55(5):1094–1100. doi: 10.1128/iai.55.5.1094-1100.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rosengarten R., Wise K. S. Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science. 1990 Jan 19;247(4940):315–318. doi: 10.1126/science.1688663. [DOI] [PubMed] [Google Scholar]
  34. Rosengarten R., Wise K. S. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation. J Bacteriol. 1991 Aug;173(15):4782–4793. doi: 10.1128/jb.173.15.4782-4793.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rosengarten R., Yogev D. Variant colony surface antigenic phenotypes within mycoplasma strain populations: implications for species identification and strain standardization. J Clin Microbiol. 1996 Jan;34(1):149–158. doi: 10.1128/jcm.34.1.149-158.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ross R. F., Dale S. E., Duncan J. R. Experimentally induced Mycoplasma hyorhinis arthritis of swine: immune response to 26th postinoculation week. Am J Vet Res. 1973 Mar;34(3):367–372. [PubMed] [Google Scholar]
  37. Sadziene A., Thompson P. A., Barbour A. G. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis. 1993 Jan;167(1):165–172. doi: 10.1093/infdis/167.1.165. [DOI] [PubMed] [Google Scholar]
  38. Seifert H. S., So M. Genetic mechanisms of bacterial antigenic variation. Microbiol Rev. 1988 Sep;52(3):327–336. doi: 10.1128/mr.52.3.327-336.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Simmons W. L., Zuhua C., Glass J. I., Simecka J. W., Cassell G. H., Watson H. L. Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect Immun. 1996 Feb;64(2):472–479. doi: 10.1128/iai.64.2.472-479.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sădziene A., Rosa P. A., Thompson P. A., Hogan D. M., Barbour A. G. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med. 1992 Sep 1;176(3):799–809. doi: 10.1084/jem.176.3.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Theiss P., Karpas A., Wise K. S. Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation. Infect Immun. 1996 May;64(5):1800–1809. doi: 10.1128/iai.64.5.1800-1809.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Webster A. D., Furr P. M., Hughes-Jones N. C., Gorick B. D., Taylor-Robinson D. Critical dependence on antibody for defence against mycoplasmas. Clin Exp Immunol. 1988 Mar;71(3):383–387. [PMC free article] [PubMed] [Google Scholar]
  43. Wise K. S. Adaptive surface variation in mycoplasmas. Trends Microbiol. 1993 May;1(2):59–63. doi: 10.1016/0966-842X(93)90034-O. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wise K. S., Watson R. K. Mycoplasma hyorhinis GDL surface protein antigen p120 defined by monoclonal antibody. Infect Immun. 1983 Sep;41(3):1332–1339. doi: 10.1128/iai.41.3.1332-1339.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yogev D., Rosengarten R., Watson-McKown R., Wise K. S. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences. EMBO J. 1991 Dec;10(13):4069–4079. doi: 10.1002/j.1460-2075.1991.tb04983.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yogev D., Watson-McKown R., Rosengarten R., Im J., Wise K. S. Increased structural and combinatorial diversity in an extended family of genes encoding Vlp surface proteins of Mycoplasma hyorhinis. J Bacteriol. 1995 Oct;177(19):5636–5643. doi: 10.1128/jb.177.19.5636-5643.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES